Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.
BACKGROUND
Nomograms are statistical tools designed to predict outcomes. This study evaluates the effects of peri-operative chemotherapy on the accuracy of a prognostic nomogram for disease-specific survival (DSS) after resection of colorectal liver metastases (CRLM) established at Memorial-Sloan Kettering Cancer Center (MSKCC).


METHODS
An external cohort of 203 patients who underwent resection of CRLM between 1996 and 2006 was used to assess the nomogram.


RESULTS
After median follow-up of 30.4 months (range 0.33-150), Kaplan-Meier (KM) estimates for 3-, 5- and 8-year post-resection DSS were 56%, 41%, and 32%, respectively; similar to nomogram-predicted probabilities for DSS. The concordance index for the nomogram was higher (0.602) than for the Fong colorectal risk score (CRS; 0.533). KM DSS was longer for patients (n= 50) treated with at least 6 months of peri-operative irinotecan or oxaliplatin compared with all other patients (median 66 vs. 40 months, P= 0.06). KM DSS was greater than nomogram predicted DSS for treated patients and less than nomogram predicted DSS for all other patients.


CONCLUSIONS
The CRLM nomogram was validated by an external cohort and more accurately predicted post-resection survival than the commonly used CRS. Differences in observed and nomogram-predicted survival may reflect the effect of treatment factors, such as peri-operative chemotherapy.
Reddy
Srinevas K
SK
Kattan
Michael W
MW
Yu
Changhong
C
Ceppa
Eugene P
EP
de la Fuente
Sebastian G
SG
Fong
Yuman
Y
Clary
Bryan M
BM
White
Rebekah R
RR